Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending EPAM Systems Q1 2026 Earnings Solid EPS Beat Amid Cautious Demand SCVL Q1 2026 Earnings Earnings Miss Estimates Amid Challenging Retail Footwear Market BRFH Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction IPDN Q2 2023 Earnings Net Loss of 014 Per Share Reflects Ongoing Investment Phase RILYN Q1 2024 Earnings Significant Loss Reported Revenue Not Disclosed